UBS AG - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 31 filers reported holding REXAHN PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AG ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2014$17,000
-95.5%
19,400
-94.5%
0.00%
Q1 2014$381,000
+3710.0%
352,074
+1768.4%
0.00%
Q4 2013$10,00018,844
+1784.4%
0.00%
Q3 2013$0
-100.0%
1,000
-92.5%
0.00%
Q2 2013$6,00013,4120.00%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Northeast Financial Consultants Inc 150,000$54,0000.03%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 200,000$73,0000.02%
Benin Management CORP 83,000$30,0000.02%
TWO SIGMA SECURITIES, LLC 36,129$13,0000.02%
NIXON PEABODY TRUST CO 10,000$4,0000.00%
Advisory Services Network, LLC 23,000$8,0000.00%
Sheaff Brock Investment Advisors, LLC 69,500$25,0000.00%
First Heartland Consultants, Inc. 21,500$8,0000.00%
INVESTMENT CENTERS OF AMERICA INC 10,000$4,0000.00%
Renaissance Technologies 1,266,400$460,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders